Abstract
Most alphaviruses maintain an in-frame opal stop codon that interrupts their nonstructural polyprotein (nsP) ORF between nsP3 and nsP4 in both vertebrate and insect hosts. We show that the nsP3 opal stop codon confers a replicative advantage to Sindbis virus (SINV) in RNAi-competent Aedes cells and mosquitoes but not in RNAi-deficient cells or mosquitoes. Mutation of the opal stop codon delays processing of the viral nsP polyprotein, disrupts viral replication spherule integrity, and renders viral RNA susceptible to Dicer 2 cleavage, resulting in higher antiviral siRNA responses against SINV. Similarly, these defects caused by opal codon mutations lead to increased viral RNA detection and enhanced immune signaling in vertebrate cells. Thus, a single stop codon in alphaviruses mediates a multipotent viral strategy to evade innate immune defenses across diverse hosts.
A conserved ORF-interrupting stop codon helps alphaviruses avoid triggering innate antiviral immunity across diverse hosts.
INTRODUCTION
Most alphaviruses encode an in-frame premature opal (UGA) stop codon within the nonstructural polyprotein (nsP) open reading frame at the end of the nonstructural protein 3 (nsP3) gene, just before the nonstructural protein 4 (nsP4) gene (Fig. 1A) (1). Programmed ribosomal readthrough (PRT) at this opal stop codon enables alphaviruses to produce two polyproteins from their nsP genes: Standard translation yields the nsP1-nsP2-nsP3 polyprotein (P123), whereas PRT yields the longer nsP1-nsP2-nsP3-nsP4 polyprotein (P1234) (2). Sufficient PRT is essential for viral replication, as nsP4 functions as the viral RNA polymerase required to synthesize new viral RNA (3).
Fig. 1. The mosquito RNAi pathway imposes strong selection on the alphavirus nsP3/4 opal codon.
(A) Alphaviruses encode an in-frame premature opal codon within the nonstructural open reading frame at the 3′ end of the nsP3 gene. (B) Infection rates of opal-to-sense substitution SINV variants relative to WT SINV in A. albopictus cells were assessed by quantifying virus (eGFP)–positive cells via flow cytometry, using either U4.4 cells with functional Dcr2 (Dcr2+), CRISPR-Cas9–edited Dcr2-deficient (Dcr2 KO) U4.4 cells, or (Dcr2−) C6/36 cells. Data represent the mean of at least three independent biological replicates. (C) Competitive fitness of SINV 550C variant against WT SINV 550opal in Dcr2+ U4.4 or Dcr2− C6/36 cells. WT versus WT competition was performed as a control. The data represent four independent biological replicates. Error bars represent the SEM. Two-way analysis of variance (ANOVA) with Tukey’s test for multiple comparisons. ****P < 0.0001, ***P < 0.001, **P < 0.01, and *P < 0.05. ns, not significant. (D) WT SINV (with opal codons, UGA) or 550C SINV variants (with UGC/UGU codons) were maintained for 5 days in Dcr2+ U4.4 cells or CRISPR-edited U4.4 Dcr2 KO cells. The frequencies of opal versus cysteine codons at the start and end of the infection period, as determined by small RNA-seq, are reported. The data represent three independent biological replicates. dpi, days postinfection.
Considerable interest has focused on how and why the opal codon confers a fitness advantage to alphaviruses (4–7). We recently demonstrated that the opal codon provides a fitness advantage in vertebrate cells by resolving a temperature-dependent trade-off between nsP4 expression via PRT and the efficiency of viral nsP processing (1). We showed that the opal codon at nsP3 position 550 (550opal) is strongly preferred over non-opal (sense codon) substitutions at this site in vertebrate cells grown at 37°C. However, why this opal codon is maintained in insect hosts remains unknown, since, in contrast to vertebrate cells at 37°C, non-opal substitutions are much better tolerated in vertebrate cells or Aedes albopictus–derived C6/36 mosquito cells grown at 28°C (1, 7, 8). Moreover, previous studies with distinct alphaviruses, including Sindbis virus (SINV) and Eastern equine encephalitis virus (EEEV), have shown that opal-to-cysteine substitutions may confer a replicative fitness advantage over the wild-type (WT) opal codon in mosquito C6/36 cells (1, 9). Despite this apparent fitness benefit, opal-to-sense codon substitutions are exceedingly rare (3%) in alphaviruses isolated from mosquitoes and are entirely absent in closely related insect-specific alphaviruses (fig. S1, A and B) (10–12). Thus, additional host or environmental factors must contribute to the conservation of the nsP3 opal stop codon in insect hosts.
A key factor that could select for preservation of the opal codon among alphaviruses is innate immunity in insect hosts. Alphaviruses elicit a robust small RNA response in mosquito cells, mediated primarily by the small interfering RNA (siRNA) pathway (13–15). Following viral infection, Dicer 2 (Dcr2), a key mediator in the siRNA pathway, processes viral double-stranded RNA (dsRNA) replication intermediates into 21-nt virus-derived small interfering RNAs (vsiRNAs). These vsiRNAs assemble with Argonaute 2 (Ago2) and other components of the RNA-induced silencing complex (RISC) to target nascent single-stranded viral RNA for cleavage and degradation (16, 17). However, most previous experimental passaging studies were conducted in C6/36 cells, which lack an effective antiviral RNA interference (RNAi) response due to impaired Dcr2 function (18).
We investigated whether immune pressure from RNAi might explain the retention of the opal codon in insect hosts, using the prototype alphavirus SINV as our model and genetic perturbations of RNAi pathway components in mosquito cells. Our previous study identified a polyprotein processing defect associated with viruses carrying opal-to-sense substitutions. Here, we asked whether such processing defects also alter the integrity of viral replication spherules, thereby allowing host cytoplasmic RNA nucleases (such as Dicer in insect cells) and sensors [such as retinoic acid–inducible gene I (RIG-I)–like proteins in vertebrate cells] to detect viral RNA and trigger cellular immune responses. To test this, we used cytological assays to quantify viral spherule integrity and to assess host antiviral responses, including siRNA production in insect cells and interferon (IFN) production in vertebrate cells. Our study demonstrates that by ensuring proper polyprotein processing, the conserved nsP3 opal stop codon protects alphaviruses from intracellular immune defenses across evolutionarily divergent hosts.
RESULTS
The Dcr2-dependent siRNA pathway imposes selection against non-opal codon variants
A. albopictus–derived C6/36 cells lack functional Dcr2 due to a frameshift mutation in the Dcr2 open reading frame, resulting in a Dcr2 protein that lacks the ribonuclease III domains essential for dicing activity (18). Prior work from our laboratory and others has shown that alphaviruses can tolerate certain opal-to-sense codon substitutions in mosquito cells lacking a functional Dcr2-dependent siRNA pathway which is the primary antiviral response against alphavirus infection in mosquitoes (1, 8, 9). To determine whether Dcr2 deficiency accounts for tolerance of opal codon substitutions in C6/36 cells, we tested the growth of three opal-to-sense substitution variants (550Alanine, 550Arginine, and 550Cysteine) relative to WT SINV (550opal) in Dcr2-competent U4.4 cells or Dcr2-lacking C6/36 cells. To ensure quantifiable virus growth in RNAi-competent cells, all infections were performed at a moderately high multiplicity of infection (MOI; ≥4). Consistent with our previous study (1), we found that infection rates of the 550C and 550A variants were higher than those of WT SINV (550opal) in Dcr2-lacking C6/36 cells, whereas the SINV 550R variant was less fit. In contrast, infection rates of all sense-codon variants were significantly reduced in Dcr2-competent U4.4 cells compared to WT SINV (550opal) (Fig. 1B).
Both U4.4 and C6/36 cells are derived from A. albopictus. Nevertheless, differences among these cell lines, beyond their Dcr2 status, could influence SINV infection. To compare the fitness of viral variants within isogenic host cell lines, we used CRISPR-Cas9 to generate Dcr2-knockout (Dcr2 KO) U4.4 cells, yielding a heterogeneous population in which Dcr2 was knocked out in ~82 to 85% of cells (fig. S2). Despite the incomplete nature of this knockout, infection rates of all SINV opal-to-sense variants, including SINV 550R, were comparable (550A and 550R) or higher (550C) than WT SINV (550opal) (Fig. 1B). Thus, in both C6/36 and U4.4 cells, loss of Dcr2 enhances the fitness of SINV opal-to-sense variants.
Our recent detailed analysis of the SINV opal codon in Dcr2-deficient mosquito cells revealed cysteine as the most tolerated sense codon (1). SINV-strain S.A. AR86 also encodes a cysteine instead of the nsP3 opal codon (19–21). Therefore, we conducted all subsequent comparative analyses using WT SINV (550opal) and SINV 550C. Consistent with the independent growth assays, our competition experiments demonstrated that SINV 550C has significantly lower fitness than 550opal in Dcr2-competent U4.4 cells, but higher fitness than WT SINV in Dcr2-lacking C6/36 cells (Fig. 1C), confirming our previous findings (1).
We also assessed the selective pressure exerted by intact Dcr2 by tracking SINV 550C variants across three independent replicate lineages over a 5-day growth period, which roughly corresponds to 24 rounds of replication (Fig. 1D). We observed that SINV 550C was nearly completely replaced by 550opal in Dcr2-competent U4.4 cells, indicating that mutations reverting 550C to 550opal had occurred and spread through the population within just 24 rounds of replication. In contrast, 550C variants persisted in U4.4 Dcr2 KO cells (Fig. 1D). Conversely, WT SINV 550opal almost entirely converted to 550sense variants, primarily 550C (UGC or UGU codons), within 5 days in U4.4 Dcr2 KO cells. However, WT SINV 550opal variants persisted in Dcr2-competent U4.4 cells (Fig. 1D). The swift accumulation of opal-to-sense substitutions in Dcr2 KO U4.4 cells mirrors previous findings in EEEV, which also develops opal-to-Cys mutations after long-term passaging in Dcr2-deficient C6/36 cells (9). Overall, our results show that Aedes Dcr2 applies strong selective pressure to maintain the SINV opal codon (Fig. 1).
We next tested whether the in vitro fitness differences between SINV 550opal and SINV 550C translated into altered infection outcomes in Aedes mosquitoes. For this, we used two reagents. The first is a previously published Aedes aegypti Dcr2 loss-of-function mutant generated by transcription activator-like effector nucleases (TALEN), in which a constitutively expressed enhanced green fluorescent protein (eGFP) knock-in cassette disrupts Dcr2 (22). Second, we generated a CRISPR-Cas9–mediated Dcr2 KO line with a constitutively expressed dsRED inserted into Dcr2, thereby disrupting the open reading frame (Fig. 2A) (23). Trans-heterozygous expression of eGFP and dsRED allows us to visually track the independent insertions in loss-of-function mutants. By crossing the independent heterozygous A. aegypti lines, we generated a trans-heterozygous Dcr2 KO (Fig. 2B, yellow). We tested Dcr2 loss of function by analyzing survival curves following systemic infection with WT SINV (550opal). Consistent with previous data in homozygous Dcr2-null eGFP mosquitoes, trans-heterozygous Dcr2-null mosquitoes showed a lethal phenotype compared to their WT siblings (Fig. 2C) (22, 23).
Fig. 2. The mosquito RNAi pathway imposes strong selection on SINV nsP3 opal codon in vivo.
(A and B) (Top) Schematic of TALEN-mediated HDR integration to generate Dcr2-null transgenic lines with the knock-in of a frame-disrupting pUb-eGFP marker. (Middle) Schematic of CRISPR-Cas9–mediated Dcr2-null transgenic lines with the knock-in of a frame-disrupting pUb-dsRED marker. Photographs are representative of the eGFP or dsRED-expressing mosquitoes selected for crossing experiments (B) to generate WT (Dcr2+/+, black) or trans-heterozygous Dcr2-null (Dcr2−/−, yellow) mosquitoes (bottom). (C) Survival of sibling WT (black line) or trans-heterozygous Dcr2-null (yellow line) mosquitoes following systemic SINV infections. Survival curves represent cohorts of ≥28 adult female mosquitoes infected with 106 median tissue culture infectious dose (TCID50)/ml of WT SINV (550opal). Significance was determined using the log-rank (Mantel-Cox) test (****P < 0.0001). (D and E) WT (Dcr2+/+) or Dcr2-null (Dcr2−/−) A. aegypti mosquitoes were infected with SINV 550opal or 550C. Three days postinfection, viral RNA was quantified via qRT-PCR. The data represent three independent biological replicates, each consisting of five pooled mosquitoes. Reported values are normalized to 550opal RNA levels in WT mosquitoes. (F and G) Viral loads were assessed from individual (D) WT (Dcr2+/+, black) or (E) homozygous Dcr2-null (Dcr2−/−, yellow) mosquitoes (n = 15) collected 3 days postinfection. Error bars represent the SEM. Unpaired t tests. **P < 0.01 and *P < 0.05.
We then challenged WT or Dcr2−/− knockout sibling A. aegypti mosquitoes with equal doses of WT SINV (550opal) or the 550C SINV variant (fig. S3). Consistent with our in vitro findings, total viral RNA levels in SINV 550C-infected WT mosquitoes were fourfold lower than those in SINV 550opal-infected WT mosquitoes 3 days postinfection (Fig. 2D). This indicates that SINV 550C experiences a significant fitness loss in WT mosquitoes. As expected, loss of Dcr2 significantly increased infection levels for both WT SINV (550opal) and SINV 550C. Viral RNA levels in SINV 550C-infected Dcr2−/− mosquitoes were statistically indistinguishable from those in WT SINV (550opal)-infected Dcr2−/− mosquitoes (Fig. 2E).
We also assessed in vivo viral fitness by quantifying the infectious virus titer recovered from infected mosquitoes. Consistent with total viral RNA levels, we recovered fivefold less infectious virus from SINV 550C-infected Dcr2+/+ mosquitoes than from those infected with WT SINV (550opal) (Fig. 2F). As expected, we recovered significantly more infectious virus from Dcr2−/− mosquitoes for both viruses [two-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test, P < 0.01 for 550opal and P < 0.0001 for 550C]. In addition, the levels of recovered virus were equivalent between WT SINV (550opal) and SINV 550C-infected Dcr2−/− mosquitoes (Fig. 2G). These findings confirm that the SINV opal codon confers a significant replicative advantage in vivo and that RNAi loss rescues the in vivo fitness defects of the SINV 550C variant (22, 23). Our present findings in SINV echo previous findings on O’nyong-nyong virus (ONNV) in Anopheles gambiae mosquitoes (4).
Opal-to-Cys substitution induces higher small RNA response in Dcr2-competent mosquito cells
Because SINV 550C exhibits reduced fitness in Dcr2+ cells, we hypothesized that this variant might elicit a more pronounced siRNA response than WT SINV (550opal). To test this, we performed small RNA sequencing (RNA-seq) of Dcr2+ U4.4 or Dcr2− C6/36 cells infected with either 550opal or 550C SINV variants (Fig. 3A). Dcr2 KO U4.4 cells were excluded from the small RNA-seq analysis because the knockout was incomplete. Although SINV 550C infected nearly 10 times fewer cells than WT SINV (Fig. 3A), virus-derived small RNA levels were significantly higher in Dcr2+ cells infected with SINV 550C than in those infected with WT SINV (550opal) (Fig. 3B). This observation directly links the lower growth of SINV 550C in Dcr2+ cells to an elevated immune response. Therefore, a single-nucleotide change (UGA to UGC) in the 11.7-kb SINV genome, which causes the loss of the nsP3 opal codon, is enough to produce a significantly higher small RNA response in mosquito cells.
Fig. 3. SINV sense-codon variant induces higher small RNA response in mosquito cells.
(A) Dcr2+ U4.4 or Dcr2− C6/36 cells were infected with WT SINV 550opal or the SINV 550C variant. Relative infection rates of SINV 550opal and 550C in Dcr2+ and Dcr2− cells used for small RNA-seq. Small RNA-seq was performed on cells collected 5 days postinfection. (B) Normalized small RNA read counts mapped to SINV genomes in Dcr2+ U4.4 or Dcr2− C6/36 cells infected with WT SINV 550opal and SINV 550C (n = 3). (C and D) Size distribution of small RNAs derived from Dcr2− C6/36 cells infected with WT SINV 550opal or SINV 550C. (E and F) Size distribution of small RNAs derived from Dcr2+ U4.4 cells infected with WT SINV 550opal or SINV 550C. The data represent three independent biological replicates. (G) Schematic of the mosquito RNAi pathway and the roles of Dcr2 and Ago2 in virus restriction. (H) Quantification of relative Ago2 transcript levels by qRT-PCR in Dcr2+ mosquito cells (n = 3) treated with Ago2 dsRNA (dsAgo2). The dotted line denotes the expected trend from a one-phase exponential decay model. Bands represent the 95% confidence interval. (I) Effect of dsAgo2 treatment on the replication (RLU, relative luciferase units) of WT SINV 550opal and SINV 550C in Dcr2+ mosquito cells as quantified by luciferase assay. Error bars represent the SEM. The data represent five independent biological replicates. Student’s t tests. ****P < 0.0001, ***P < 0.001, **P < 0.01, and *P < 0.05.
To further analyze the nature of the small RNA response, we examined small RNAs by size distribution and polarity (Fig. 3, C to F, and fig. S4, A to D). As expected, the siRNA response to either SINV 550C or SINV 550opal was significantly reduced in C6/36 cells lacking Dcr2 (Fig. 3, C and D). In addition, all small RNAs in C6/36 cells showed a bias toward the sense strand. In Dcr2-competent U4.4 cells, levels of 21-nt vsiRNAs were notably higher in SINV 550C-infected cells compared to 550opal-infected cells (Fig. 3, E and F), consistent with SINV 550C’s increased susceptibility to Dcr2-mediated processing (Fig. 3B). We also detected clear differences in siRNA polarity between the two viral variants. siRNAs originating from 550opal mapped equally to sense and antisense viral RNA, indicating that they arise from dsRNA replication intermediates, where sense and antisense RNAs are in equal amounts (paired t test: P = 0.976; Fig. 3E). Conversely, 550C-derived siRNAs showed a strong bias toward the sense strand (paired t test: P < 0.05; Fig. 3F). Our results suggest that siRNAs produced in SINV 550C-infected cells are more plentiful than those in WT SINV (550opal)-infected cells and stem from single-stranded positive-sense viral RNA rather than dsRNA. We considered two complementary mechanisms by which increased siRNA production during SINV 550C infection in Dcr2-competent U4.4 cells could directly reduce fitness (Fig. 3G, top). First, Dcr2-mediated cleavage of viral dsRNA could inherently harm the virus by disrupting minus-strand replication. This could lead to a proportional reduction in intact viral dsRNA, which might be enough to lower viral fitness. Alternatively, viral siRNAs produced by Dcr2 can be targeted to degrade new viral RNA via Ago2, thereby restricting viral replication (Fig. 3G, bottom). To distinguish between these two mechanisms, we tested whether Ago2-mediated targeting of vsiRNAs to viral RNAs is necessary for SINV 550C inhibition. We performed Ago2 knockdown in Dcr2+ U4.4 cells using dsRNA, achieving more than 90% knockdown within 48 hours (Fig. 3, G and H, and fig. S5A). If both cleavage and Ago2 targeting play significant antiviral roles, then Ago2 knockdown should only modestly affect viral fitness (Fig. 3G). However, contrary to this expectation, Ago2 knockdown greatly increased SINV 550C replication to levels similar to WT SINV (550opal) (Fig. 3I). This shows that Ago2-mediated vsiRNA targeting of viral RNA significantly contributes to the reduced fitness of SINV 550C in Dcr2+ cells.
In addition to vsiRNAs, we also detected viral-derived 24- to 31-nt piwi-interacting RNAs (piRNAs) in both C6/36 and U4.4 cells, consistent with previous studies (Fig. 3, C to F, and figs. S6, S7, and S8A) (14, 15, 23). In mosquito cells, viral piRNAs (vpiRNAs) are primarily generated via a ping-pong–like mechanism involving specific PIWI proteins, including Ago3 and Piwi5 (24–26). Consistent with earlier findings, we observed that SINV-derived piRNA reads primarily originate from the subgenomic RNA, especially from a hotspot at the 5′ end of the capsid gene (fig. S6B), through a canonical ping-pong amplification pathway, as indicated by the 1U bias in antisense and 10A bias in sense piRNAs (fig. S8C). Like siRNAs, C6/36 cells produce significantly fewer viral-derived piRNAs than U4.4 cells (Fig. 3, C and D, and fig. S6). Dcr2+ U4.4 cells infected with the SINV 550C variant also produce 24- to 31-nt viral-derived piRNAs at levels 12 times higher than the WT SINV variant (Fig. 3, E and F, and fig. S8A). Conversely, SINV 550C infection leads to a twofold decrease in small RNAs in mosquito cells lacking Dcr2, which show an almost complete absence of vsiRNA and vpiRNA production (Fig. 3, B and C). Therefore, although vpiRNA production is traditionally considered independent of mosquito Dcr2 activity, our results add to the growing evidence of a functional interaction between the siRNA pathway and ping-pong–generated piRNA production in mosquitoes (25, 27–29). Unlike viral-derived siRNAs, which have been shown to restrict alphavirus replication in insect cells, the antiviral role of viral-derived piRNAs remains less clear (30). In our study, we observed no significant differences in the levels of subgenomic RNA template or structural protein expression between WT SINV (550opal)- infected and SINV 550C-infected Dcr2+ cells (fig. S8D). Moreover, since knockdown of Ago2, which is involved in siRNA but not piRNA targeting, was sufficient to restore the fitness of the SINV 550C variant to WT levels in U4.4 cells (Fig. 3I), we conclude that viral-derived piRNAs do not play a substantial antiviral role and do not discuss them further in this study.
SINV structured RNA element protects against RNAi in mosquito cells
To determine whether specific SINV genomic regions serve as Dcr2 substrates in WT SINV and especially in SINV 550C-infected cells infected, we mapped all 21-nt vsiRNA reads to the SINV reference genome. Using a 40-nt sliding window across the SINV genome, we identified regions with higher-than-average vsiRNA coverage (Fig. 4A). Since infection with the SINV 550C variant induces a stronger siRNA response than WT SINV (550opal), we mainly focused on regions with significantly higher vsiRNA coverage in SINV 550C compared to WT SINV (550opal) (Fig. 4B). This differential analysis uncovered several windows in the SINV genome that produced disproportionately more vsiRNAs during infection with the SINV 550C variant. The most notable was a 23-nt stretch within the E1 structural gene coding region. This “hotspot,” which we named E1-hs, made up more than 4% of total siRNA reads in SINV 550C (99.85th percentile). E1-hs is also a hotspot in SINV 550opal, contributing 1% of total siRNA reads (96th percentile) (Fig. 4, A and B).
Fig. 4. A structured RNA element enables SINV to blunt the siRNA response.
(A) Distribution of vsiRNA reads from WT SINV 550opal (in black) or SINV 550C (in red) viruses in Dcr2+ U4.4 cells. Positive and negative y axis values represent read counts mapped to the sense and antisense strands, respectively, at every position along the SINV genome (x axis). The inset shows a zoomed-in view of the E1-hs region. (B) Correlation of per-site vsiRNA reads mapped to WT SINV 550opal or SINV 550C viruses. Residues within the E1-hs region are boxed and colored in red. (C) Density distribution profile of median SHAPE values of SINV RNA. Median SHAPE values of residues within the E1-hs region are boxed and highlighted in red. Location of the E1-hs region in SHAPE-constrained RNA secondary structure. (D) Schematic of viral genomes with intact (WT) and mutated E1-hs (E1-hsmut). Positional entropy profile of E1-hs RNA structural element in WT SINV and the E1-hsmut strain. High and low entropy values indicate conformationally flexible and rigid structures, respectively. (E and F) Replication of WT SINV 550opal or SINV 550C viruses with intact or destabilized E1-hs structure in Dcr2− C6/36 cells (E) and Dcr2+ U4.4 cells (F) as quantified via luciferase reporter assays. The data represent six independent biological replicates. (G) Relative replication levels of SINV 550C viruses with intact or destabilized E1-hs structure in Dcr2+ U4.4 cells in the presence or absence of Ago2, normalized to WT SINV replication (550opal; horizontal dotted line). The data represent five independent biological replicates. ***P < 0.001 and **P < 0.01.
The SINV RNA genome contains several structural RNA elements vital for replication, expression, and packaging (31). Because of the biased polarity of vsiRNAs derived from SINV 550C, these elements could serve as hotspots for disproportionately large amounts of viral-derived siRNAs. vsiRNA reads mapping to the E1-hs region showed a strong bias toward the sense strand (Fig. 4A, inset), suggesting that these E1-hs siRNAs may originate from a structured RNA element in the SINV genome. To determine whether E1-hs corresponds to a structured RNA, we analyzed previously generated SINV RNA SHAPE-MaP data by Kutchko et al. (31) to calculate and visualize the median SHAPE reactivity values across a 40-nt sliding window throughout the SINV genome. Residues within the E1-hs region displayed notably negative SHAPE reactivity values, indicating that they are part of highly structured RNA in SINV (Fig. 4C). We determined the RNA secondary structure conservation of the E1-hs element using RNAalifold and a multiple-sequence alignment of 2086 alphavirus sequences collected from Bacterial and Viral Bioinformatics Resource Center (BV-BRC). We then mapped the corresponding E1-hs region to the Chikungunya virus (CHIKV) Selective 2ʹ-hydroxyl Acylation Analyzed by Primer Extension and Mutational Profiling (SHAPE MaP) data (fig. S9C) described in Madden et al. (32). Thus, as with SINV, the E1-hs sequence also appears to be part of structured RNA in CHIKV (fig. S9C) and likely in other alphaviruses. In addition, we compared genome-wide vsiRNA profiles between SINV 550C and Semliki Forest virus (SFV) using previously collected data from Siu et al. (15) from SFV4-infected Dcr2+ U4.4 (A. albopictus) and Aag2 (A. aegypti) cells. This comparison identified several hotspots of vsiRNA production, including the SINV E1-hs region, which is shared by both viruses despite their high overall sequence divergence (fig. S10, A and B).
To evaluate the functional importance of the E1-hs hotspot, we introduced synonymous mutations that disrupt the E1-hs secondary structure without changing the E1 protein-coding sequence (Fig. 4D). We then compared the replication efficiency of these E1-hsmut variants with that of their WT counterparts in both SINV 550C and SINV 550opal viruses in Dcr2− (C6/36) cells. In Dcr2− cells, SINV E1-hsmut replicated at levels indistinguishable from WT SINV, and SINV 550C E1-hsmut replicated at levels comparable to SINV 550C (Fig. 4E). Thus, E1-hsmut variants do not intrinsically impair viral replication. We then investigated the effect of the E1-hs mutation in Dcr2+ cells. Although the replication of the SINV 550opal E1-hsmut variant was comparable to that of SINV 550opal, SINV 550C E1-hsmut replicated to significantly lower levels than SINV 550C in Dcr2+ cells (Fig. 4F). Replicative fitness of SINV 550C E1-hsmut was also rescued to WT SINV levels in Dcr2+ cells following Ago2 knockdown, indicating that E1-hs helps sustain viral fitness under active RNAi targeting (Fig. 4G). Thus, the ability of E1-hs to produce excess vsiRNAs is vital for preserving the fitness of the 550C variant in Dcr2+ cells, since the SINV 550C genome is more vulnerable to Dcr2 targeting. Our results show that the SINV opal codon and the E1-hs structure work together as a powerful RNAi evasion strategy.
Disrupted nsP processing compromises the integrity of viral replication spherules and increases susceptibility to mosquito RNAi
We next asked why the SINV 550C variant is much more susceptible to RNAi than WT SINV (550opal). We previously found that opal-to-sense substitutions cause overproduction of the full-length nsP (P1234), thereby disrupting polyprotein processing kinetics. These differences in polyprotein processing between WT SINV and sense-codon variants are most prominent in vertebrate cells cultured at 37°C but also appear (although less strongly) in both vertebrate and mosquito cells maintained at 28°C (1). Specifically, less P123 is produced early during infection in SINV 550C-infected Dcr2+ cells, presumably due to delayed P3/4 processing caused by excess P1234 (fig. S11, A and B). We therefore considered whether functional RNAi could worsen delays in polyprotein processing. However, similar polyprotein processing trends were seen in Dcr2+ (U4.4) and Dcr2− (C6/36) mosquito cells at 28°C (fig. S11, A to D), ruling out the possibility that RNAi status influenced SINV nsP polyprotein processing.
The SINV nsP1 I538T mutation also slows P1/2 processing, and we recently showed that it helps restore the disruption in nsP processing cadence caused by the 550C mutation by creating a “double delay” (1). Therefore, we tested whether SINV 550C replication is improved by the nsP1 I538T mutation in Dcr2+ cells. However, we did not observe any appreciable improvement in the replication of SINV 550C + I538T compared to SINV 550C, suggesting that the double delay may not enhance spherule integrity defects in a timely manner to prevent RNAi susceptibility (fig. S11E).
Next, we investigated whether the increased RNAi susceptibility of the SINV 550C variant was due to increased viral dsRNA production, which could lead to higher antiviral vsiRNA output in Dcr2+ cells. This increase in dsRNA could directly result from the nsP processing defect, which delays transitions from minus-strand to plus-strand replication. We have previously used a quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay to measure intracellular levels of SINV genomic RNA, including both plus and minus strands (1). However, we were concerned that Dcr2 cleavage of viral dsRNA might prevent accurate measurement of viral dsRNA levels within cells. Therefore, to detect both intact and potentially processed dsRNA, we used the J2 monoclonal antibody, which has been well characterized for detecting dsRNAs ranging from 14 to 40 bp (33). We performed immunofluorescence microscopy on Dcr2+ (U4.4) cells, which revealed distinct J2 foci in the cytoplasm of SINV-infected cells but not in uninfected cells. These J2 foci indicate SINV replication compartments or spherules (Fig. 5A). We measured J2/dsRNA intensity within these spherules. Although the total number of spherules per cell did not change, Dcr2+ (U4.4) cells infected with SINV 550C showed a 29% increase in spherule J2 intensity compared to those infected with WT SINV (550opal), suggesting that SINV 550C replication spherules contain more J2-binding dsRNA substrate (Fig. 5, B and C).
Fig. 5. Delayed nsP processing in SINV 550C compromises the integrity of viral replication spherules.
(A) Confocal microscopy–based localization of viral dsRNA (J2, in yellow) and virally encoded eGFP (in cyan) in Dcr2+ U4.4 cells that were either uninfected (top row), infected with WT SINV 550opal (middle row), or infected with SINV 550C (bottom row). The inset shows the localization of eGFP and dsRNA around (middle row) or within (bottom row) viral replication spherules. White arrowheads indicate spherule outer boundaries. (B) Spherule count per cell (n = 17) is reported as the mean number of spherules per cell in each z-stack. (C) Quantification of J2 intensities within viral replication spherules (n = 629) in Dcr2+ U4.4 cells infected with either WT SINV 550opal or SINV 550C. Mann-Whitney U test. ****P < 0.0001. Error bars represent the SEM. (D) Density distributions of observed values of spherule eGFP intensity in WT SINV 550opal or SINV 550C-infected Dcr2+ cells. Kolmogorov-Smirnov test = 0.862, P < 0.0001. (E and F) Correlation between mean dsRNA and eGFP intensities per spherule across Dcr2+ cells infected with either WT SINV 550opal or SINV 550C. Spearman’s correlation tests [(E) and (F): P < 0.0001].
Recent cryo–electron microscopy reconstruction of WT alphavirus replication organelles showed that each spherule contains only a single full-length viral dsRNA molecule (34). We therefore wondered whether the accumulation of Dcr2-processed dsRNA fragments could increase spherule J2 intensity in SINV 550C-infected Dcr2+ cells. To test this, we performed a similar analysis in Dcr2− C6/36 cells (fig. S12A). We reasoned that if SINV 550C naturally synthesizes excess full-length dsRNA, we would also expect a similar increase in spherule J2 signal in cells lacking Dcr2. However, we found no significant differences in spherule J2 intensities between WT and SINV 550C-infected C6/36 cells (fig. S12, B and C). These findings confirm both our previous small RNA-seq analyses showing greater siRNA production in SINV 550C-infected U4.4 cells and our hypothesis that the increased spherule J2 signal in SINV 550C-infected U4.4 cells (Fig. 5, B and C) reflects an excess of processed dsRNA fragments.
Another consequence of nsP processing defects in cells infected with the SINV 550C variant could be compromised integrity or permeability of mature viral replication spherules, which are composed of processed nonstructural proteins. Initial alphavirus replication spherule formation requires the intact P123 polyprotein, while spherule maturation depends on further processing into nsPs 1 to 4 (35, 36). Formation of replication spherules is a passive but highly effective viral evasion tactic that hides viral dsRNA replication intermediates from cellular RNA sensors and effectors, including Dcr2 (37, 38). The presence of processed dsRNA within or near replication spherules in SINV 550C-infected Dcr2+ cells suggests that mature spherule formation is delayed in SINV 550C because of abnormal processing of the P123 polyprotein, which weakens the structural integrity of replication complexes, increases spherule permeability, and allows cytoplasmic Dcr2 access to cleave viral dsRNA. To test this idea, we measured spherule integrity by assessing their ability to block cytoplasmic eGFP.
If viral spherule integrity were intact, then we would expect to see occlusion of the normally freely diffusing cytoplasmic eGFP. Two-dimensional (2D) plot profile analysis of dsRNA-containing intact spherules (identified using the J2 antibody) in Dcr2+ cells infected with eGFP-expressing WT SINV (550opal) showed a clear reduction in eGFP intensity within spherules compared to areas outside the spherule boundary, indicating the selective exclusion of cytoplasmic eGFP from the viral spherule compartment (fig. S12D). In contrast, within-spherule eGFP intensity was markedly higher in SINV 550C-infected cells. When we examined a larger number of J2-marked viral replication spherules in Dcr2+ cells infected with WT SINV (550opal), we observed a bimodal distribution of spherule eGFP intensity values: Most spherules exclude eGFP entirely, while only a very small subgroup of spherules appears to overlap with eGFP (Fig. 5D). Conversely, in SINV 550C-infected cells, spherule eGFP intensity values displayed a broader unimodal distribution, indicating much more eGFP leakage into spherules (Fig. 5D). Therefore, we conclude that, in SINV 550C-infected cells, few viral replication spherules exclude eGFP, whereas most do not. We also found a positive correlation between J2 intensity and eGFP intensity within individual spherules in WT SINV-infected Dcr2+ cells (Fig. 5E). This correlation was even stronger in SINV 550C-infected cells, suggesting that impaired spherule integrity is linked to higher levels of processed dsRNA in a subset of spherules (Fig. 5F).
The SINV opal-to-Cys variant induces a higher IFN response in human cells
Our previous study showed that the nsP-processing defects of the SINV 550C variant also occur in vertebrate cells (1). Unlike in insects, RNAi is not the primary immune defense pathway in vertebrate cells. Instead, host-encoded pattern recognition receptors, RIG-I (Retinoic acid-inducible gene I) and MDA5, detect viral dsRNA and trigger downstream IFN responses (39, 40). On the basis of our findings that nsP-processing delays cause spherule integrity defects in mosquito cells, we reasoned that similar spherule defects occur during SINV 550C infection in vertebrate cells, thereby activating dsRNA sensors and inducing innate immune responses. If so, we would expect SINV 550C-infected cells to trigger a stronger immune response than WT SINV (550opal)-infected cells.
We tested this hypothesis by infecting human A549 cells with either SINV 550C or SINV 550opal for 16 hours and then monitoring changes in immune gene expression using bulk RNA-seq. Consistent with our expectations, we observed increased expression of several antiviral IFN-stimulated genes (ISGs) and genes related to type I/III IFN responses in SINV 550C-infected cells (Fig. 6, A and B), indicating that the loss of the opal codon may result in higher IFN production and signaling in vertebrate cells.
Fig. 6. The SINV sense-codon variant induces a higher immune response in human cells.
(A) Volcano plot of differentially expressed genes between A549 cells infected with WT (550opal) and variant (550C) SINV. ISGs and other immune-related genes are represented as green circles. (B) Changes in immune-associated gene expression 16 hours postinfection with WT (550opal) and variant (550C) SINV in human A549 cells. RLR and MAVS expression are highlighted with asterisks (*). (C) Experimental workflow to measure IFN production in A549 cells infected with either WT SINV 550opal or SINV 550C at an MOI of 5. Huh7 cells expressing a 5XISGF3-GLuc reporter were treated for 24 hours with A549 cell supernatants, and secreted Gaussia luciferase was quantified. Reporter activity in 5XISGF3-GLuc Huh7 cells treated with supernatants collected 16 hours postinfection from WT, MDA5 KO, RIG-I KO, or MAVS KO A549 cells. The data represent the mean of four independent biological replicates. Two-way ANOVA with Sidak’s multiple comparisons test. ****P < 0.0001 and *P < 0.05.
To test this, we measured IFN production from infected A549 cells in Huh7 cells expressing a 5XISGF3-GLuc reporter (Fig. 6C, left) (41). Consistent with the transcriptomic response, we observed significantly higher GLuc activity in cells treated with supernatants from SINV 550C-infected A549 cells than in those treated with supernatants from WT SINV (550opal)-infected A549 cells (Fig. 6C, right).
A549 cells respond to dsRNA by up-regulating RLRs (RIG-I–like receptors)—RIG-I and MDA5 (42). Both RLRs signal through the downstream adapter MAVS (mitochondrial antiviral signaling protein) and are crucial for IFN induction during alphavirus infection (40). After confirming elevated expression of RIG-I and MDA5 in SINV 550C-infected cells (Fig. 6B), we asked whether these RLRs are functionally important for immune stimulation in response to SINV 550C infection by quantifying IFN production in their presence and absence (Fig. 6C, right). First, we asked whether MDA5, the cytoplasmic RNA sensor that detects long dsRNA, is responsible for elevated IFN production. We infected MDA5 KO A549 cells with either SINV 550C or WT SINV (550opal) and measured the IFN response at 16 hours postinfection. We found that MDA5 loss significantly reduced, but did not ablate, IFN production in SINV 550C-infected A549s (Fig. 6C, right). However, loss of RIG-I (RIG-I KO) or the adapter MAVS (MAVS KO) led to near-complete loss of IFN production in SINV 550C- and WT SINV (550opal)-infected A549s (Fig. 6C, right). These results suggest that human RLRs, primarily RIG-I and MDA5, contribute to ligand detection when viral spherule integrity is compromised in SINV-infected human cells.
We next asked whether the S.A. AR86-specific nsP1 I538T mutation alters the SINV 550C-induced immune response. The Thr (T) residue at nsP1 position 538 has previously been shown to be necessary and sufficient to prevent immune activation in S.A. AR86 by inhibiting Janus kinase/signal transducer and activator of transcription signaling in murine fibroblasts (43, 44). Cells infected with SINV 550C carrying the I538T mutation produced less IFN than SINV 550C (fig. S13). However, consistent with our earlier observation in RNAi-competent mosquito cells, which suggests that an I538T-induced delay in nsP processing may also promote IFN induction, we observed higher IFN levels in cells infected with SINV carrying an I538T mutation relative to WT SINV (550opal) (fig. S13).
Overall, our data support a model in which delayed nsP processing, caused by an opal-to-Cys substitution at the stop codon between nsP3 and nsP4, produces defective or incomplete spherules in alphavirus-infected cells (Fig. 7). These structurally compromised spherules allow cytoplasmic proteins, including RNA sensors like Dcr2 in insect cells and RLRs RIG-I and MDA5 in vertebrate cells, to access viral dsRNA. This access enhances immune activation and ultimately lowers viral fitness in immune-competent insect and vertebrate cells (Fig. 7B). Therefore, the nearly universally conserved nsP3 opal codon in alphaviruses is crucial for hiding viral RNA replication and preventing immune activation in both insect and vertebrate hosts.
Fig. 7. Proposed model of how opal-to-sense codon substitutions reduce viral fitness.
(A) The SINV nsP3 opal codon helps maintain replication spherule integrity to avoid detection of viral RNA by cytoplasmic RNA nucleases (Dcr2) or sensors (RIG-I and MDA5) in mosquito or vertebrate cells, respectively. (B) Improper processing of the nsP polyprotein in SINV 550C variant–infected cells leads to the loss of spherule integrity, resulting in excessive Dcr2- and Ago2-mediated antiviral RNAi induction in mosquito cells and RIG-I/MDA5–mediated, MAVS-dependent IFN induction and ISG expression in vertebrate cells. PRRs, pattern recognition receptors.
DISCUSSION
Our study demonstrates that retaining the highly conserved nsP3 opal stop codon is a multipotent defense strategy used by alphaviruses (Fig. 7A). By systematically dissecting its function in both insect and vertebrate cells, we find that the opal codon is crucial not only for a temperature-dependent trade-off between nsP production and processing, as we previously showed (1), but also for maintaining the physical integrity of replication spherules, thereby shielding viral dsRNA from host immune sensors. We find that opal-to-sense substitutions (e.g., SINV 550C) disrupt the cadence of alphavirus nsP processing, leading to spherules with compromised integrity and increased exposure of viral dsRNA (Fig. 7B). This defect enables cytoplasmic Dcr2 in mosquitoes to access and process viral dsRNA, triggering a robust antiviral siRNA response that sharply reduces viral fitness in RNAi-competent A. albopictus cell lines and A. aegypti mosquitoes in vivo (Figs. 1B, 2, C to G, and 7B). Using small RNA-seq, we show that SINV 550C, which differs from WT SINV by a single nucleotide at the opal codon, induces a significantly higher small RNA response in A. albopictus cells (Fig. 3B). This direct measurement of RNAi activity in response to WT and variant SINV infections provides conclusive evidence for the role of RNAi in the fitness advantage conferred by the opal codon. These findings extend earlier work in A. gambiae, where an opal-to-arginine mutation reduced in vivo ONNV infectivity, underscoring the evolutionary importance of preserving the opal codon for efficient vector transmission (4). We also show that alphaviral structural RNA elements, such as E1-hs, protect viral fitness against host RNAi by acting as “decoy” hotspots of vsiRNA production, likely blunting the antiviral RNAi response (Fig. 4, C to G). Thus, alphaviruses use a two-pronged defense strategy against mosquito RNAi: first, by physically sequestering dsRNA within replication spherules, and second, by producing decoy vsiRNAs from structured genomic RNA elements. Beyond insects, compromised spherule integrity in human cells may also permit RNA sensors, such as RIG-I and MDA5, to detect viral dsRNA, thereby enhancing IFN signaling and ISG expression (Figs. 6 and 7B).
Recent in situ structural and functional characterization has provided insights into the architecture of mature alphavirus replication spherules—membrane-associated structures that shield viral dsRNA from cytoplasmic RNA sensors in vertebrate and mosquito cells (29, 45–48). Although mature spherule biogenesis remains poorly understood, it is thought to require proteolytic processing of P1234 into individual nonstructural proteins that comprise the “neck” of the replication spherule (2, 34, 35, 45, 49). Using quantitative immunoblotting and confocal microscopy, we show that incomplete polyprotein processing in SINV 550C disrupts the structural integrity and permeability of replication spherules, potentially allowing cytoplasmic Dcr2 access to viral dsRNA in infected mosquito cells (Fig. 5 and fig. S11). In addition, the J2 signal intensity in SINV 550C-infected cells exceeds that in WT SINV (550opal)-infected cells but only in the presence of Dcr2, suggesting that the excess J2 signal may represent Dcr2-processed viral dsRNA and thereby contribute to the overall increase in the siRNA response (Fig. 5C and fig. S12, B and C). Therefore, increased vsiRNA induction by SINV 550C in Dcr2+ cells correlates with slower processing of viral nsP (fig. S11). Although it is clear that the opal-to-Cys mutation increases the permeability of viral spherules, the directionality of dsRNA sensing remains unclear. Future studies, aided by new tools and advances in cryo–electron tomography, could investigate whether the higher RNAi induction in SINV 550C-infected mosquito cells is due to Dcr2 gaining access to the viral replication compartment or to viral dsRNA leaking from spherules into the host cytoplasm (45, 48).
Together, these findings suggest that although some opal-to-sense substitutions may promote viral replication in Dcr2-deficient mosquito cells, the resulting delay in polyprotein processing may compromise the integrity of replication spherules. This structural vulnerability increases viral susceptibility in the presence of Dcr2, ultimately limiting the replication efficiency of sense-codon variants in Dcr2-competent cells. Our results align with previous findings of a Dcr2-dependent change in the relative replication of CHIKV replicons carrying mutations that delay nsP processing, potentially indicating a generalizable trade-off between replication efficiency and RNAi susceptibility (50).
Because RNAi is the primary antiviral defense in mosquitoes, mosquito-transmitted viruses have evolved mechanisms to circumvent or suppress the RNAi response while maintaining persistent, nonpathogenic infections in their vectors. For example, noncoding subgenomic flaviviral RNAs (sfRNAs) at the 3′ end of flavivirus genomes outcompete native Dcr2 and Ago2 substrates for binding, thereby reducing RNAi activity (51). Other viruses, such as Flock House virus (FHV B2, Nodaviridae) and Culex Y virus (CYV VP3, Birnaviridae), encode bona fide viral suppressors of RNAi (VSRs) (52–54). Until recently, alphaviruses were not known to encode sfRNAs or proteins with strong VSR activity. SINV expressing heterologous FHV B2 exhibits high vector mortality and reduced virus transmission (55). Thus, unlike other arboviruses, alphaviruses likely avoid strong, direct suppression by RNAi, instead dampening or evading the mosquito RNAi response to maintain persistent, nonlethal infection in insect hosts. However, some alphavirus proteins exhibit VSR activity, most notably CHIKV nsP2/3 and SFV capsid, which weakly suppress RNAi in mammalian cells, potentially by sequestering viral dsRNA (56, 57). More recent work provides compelling evidence that mature SINV nsP2 also antagonizes mosquito RNAi using a similar mechanism (58). Notably, cleavage-deficient SINV nsP2 lacks VSR activity, lowering in vivo fitness in immune-competent mosquitoes. Thus, it is formally possible that lower levels of processed nsP2, caused by slower polyprotein processing, also contribute to lower SINV 550C fitness.
One intriguing model for how alphaviruses suppress mosquito RNAi comes from a study of SFV, which is unusual among alphaviruses in that it predominantly lacks the nsP3/4 opal stop codon (15). SFV genomes produce decoy vsiRNAs during infection of mosquito cells that swamp the RISC machinery, thereby protecting RNAi-susceptible viral targets. These vsiRNAs arise from genomic hotspots that correspond to structured RNA regions but are not antiviral themselves. Consistent with this decoy vsiRNA model, we identified a vsiRNA hotspot in SINV that maps to a structured RNA element within the E1 coding region (Fig. 4, A to C). Increased RNA exposure in SINV 550C-infected cells disproportionately reduces vsiRNA production from this hotspot element (Fig. 4A, inset). Disrupting this RNA secondary structure (E1-hs) significantly reduced SINV 550C replication in RNAi-competent cells, underscoring its role in RNAi evasion (Fig. 4, D to G). Structural conservation of this RNA element also suggests that it may perform a similar function in other alphaviruses (figs. S9 and S10). Our data show that such decoy strategies can be generally beneficial but are especially critical when viruses are more susceptible to Dcr2 inhibition due to defects in spherule integrity, which might be caused by genetic mutations (as we show in this study) or by other biophysical changes within host cells (Fig. 4).
Our results also demonstrate a link between alphavirus nsP processing and innate immune detection in vertebrate cells. Impaired replication spherule integrity in SINV 550C increases IFN production and antiviral ISG expression by enhancing recognition by the cytoplasmic RNA sensors RIG-I and MDA5 in human A549 cells (Fig. 6) (40). Furthermore, a mutation (nsP1 I538T) associated with slower P1/2 processing and a “double processing delay,” in combination with an opal-to-Cys substitution, also leads to higher IFN levels (fig. S13). Our findings align with recent studies showing that alphaviruses with delayed nsP processing mutations elicit stronger immune responses by generating host-derived rPAMP RNAs that serve as RLR ligands (39, 44, 59). Therefore, host-derived dsRNAs might also promote immune activation in SINV 550C-infected cells. Although our data cannot distinguish between viral- and host-derived PAMP RNAs as the source of stimulation, it is clear that IFN induction relies on detection by the RLRs RIG-I and MDA5 (Fig. 6C).
The 538Thr residue in SINV nsP1 has been shown to suppress IFN production and antagonize downstream IFN signaling, thereby increasing neurovirulence in mice (43, 60). Unexpectedly, however, we did not observe strong IFN suppression by SINV nsP1 538Thr in human cells. Although we cannot rule out the possibility that the SINV nsP1 I538T mutation might have preexisted in the original mosquito-isolated S.A. AR86 strain, it is just as likely that this mutation arose during extensive passaging (>45 passages) in mice (20, 21). Therefore, on the basis of our current data, we conclude that its immunosuppressive phenotype may be specific to mouse cells (20, 21, 43).
Collectively, the results presented in this study extend our previous model, in which the alphavirus nsP3 opal codon helps balance RdRp (RNA-dependent RNA polymerase) production and nsP processing efficiency (1). We now demonstrate that the opal codon also serves an immune-specific function by enabling alphaviruses to evade triggering an antiviral response (Fig. 7). This may also explain why the opal codon is strictly retained across insect-restricted alphaviruses that do not face vertebrate- or temperature-specific constraints described in our previous study (1).
One of the central conflicts faced by viruses infecting evolutionarily divergent host organisms is that adaptations that confer fitness benefits in one host, such as vertebrates, may be deleterious in another, such as mosquitoes. Some viral adaptations might confer benefits in both hosts. Our study highlights one adaptation—the nsP3 opal codon—that confers benefits in both hosts by maintaining replication spherule integrity and shielding viral RNA from cytoplasmic nucleases and RNA sensors (Fig. 7). In doing so, this single codon confers a fitness advantage in RNAi-competent mosquito cells while also limiting IFN responses in mammalian cells. Thus, the retention of the opal codon by alphaviruses reflects evolutionary pressure from immunity in both hosts. By demonstrating that the alphavirus opal codon is a multipurpose defensive adaptation, our work reframes a classical paradigm of alphavirus biology and opens new avenues for research into vector-borne disease control.
MATERIALS AND METHODS
Insect and mammalian cell culture
C6/36 A. albopictus cells were grown at 28°C under 5% CO2 in humidified incubators and cultured in high-glucose, l-glutamine minimal essential medium (Gibco) supplemented with 10% fetal bovine serum (Cytiva) and 1% penicillin-streptomycin (Gibco). U4.4 A. albopictus cells were grown at 28°C under 5% CO2 in humidified incubators. They were cultured in high-glucose, l-glutamine Mitsuhashi and Maramorosch insect medium without sodium bicarbonate (VWR) supplemented with sodium bicarbonate (0.12 g/liter), 10% fetal bovine serum (Cytiva), and 1% penicillin-streptomycin (Gibco). The A. albopictus U4.4 cells were a gift from D. (Doug) Brackney (University of Connecticut).
CRISPR editing of Dcr2 in U4.4 cells
A total of 5 × 105 U4.4 cells were seeded into six-well plates and cotransfected with 6.25 μg of purified SpyCas9-NLS (PNA Bio #CP01-50) and a synthesized single guide RNA (sgRNA) (AUAUUCGACGAAUGUCACCA) targeting the 5′ end of the Dcr2 gene (Synthego). The guide RNA was designed using CHOPCHOP and verified with Cas-OFFinder to assess off-target effects by searching the guide RNA sequence against the A. albopictus genome (JXUM01). The synthesized sgRNA was also modified with 5′ 2′-O-methyl analogs and 3′ phosphorothioate to enhance stability and performance. We harvested 1 × 106 cells 2 weeks after Cas9-sgRNA transfection, extracted genomic DNA, and amplified the sgRNA target region using flanking primers (see data S2 for information on the primers used in the study). Purified PCR products were sent for Sanger sequencing, and the resulting chromatograms were used for TIDE analyses (version 5.0), which revealed a knockout efficiency of 82 to 85% (fig. S2) (61).
Ago2 silencing in U4.4 cells
We used dsRNA to silence A. albopictus Ago2 in U4.4 cells, as previously described (38). Briefly, the total RNA from U4.4 cells was reverse transcribed with oligo(dT) to synthesize cDNA. The cDNA served as the template for PCR amplification of a region within the PIWI domain of Ago2, using primers with T7 promoters at the 5′ end (see data S2 for primer information). Purified PCR products were used as templates for in vitro transcription (IVT) with T7 RNA polymerase [New England Biolabs (NEB)] to generate dsRNA, which was then purified using the MEGAclear clean-up kit (Invitrogen) according to the manufacturer’s instructions. A total of 5 × 105 U4.4 cells were transfected with 500 ng of Ago2 dsRNA using Lipofectamine 3000 (Invitrogen), and Ago2 silencing was assessed over 1 to 4 days by qRT-PCR (see data S2 for information regarding primers used in the study). To determine the extent of functional disruption of the siRNA pathway following Ago2 silencing, we used a previously described eGFP reporter silencing assay with dsRNA targeting eGFP (fig. S5A) (56). Infections were performed 48 hours after Ago2 dsRNA treatment.
Small RNA-seq and analysis
Ten micrograms of total RNA was isolated from cultured U4.4 and C6/36 mosquito cells 5 days after SINV infection. RNA purity and integrity were assessed using the Agilent 4200 TapeStation. All subsequent small RNA enrichment steps were performed by Novogene, USA, using 10 μg of total RNA. Small RNA-seq was performed on an Illumina NovaSeq (Novogene, USA). Three biological replicate libraries were sequenced for each sample. After removing adaptor sequences (Trimmomatic), the processed reads were mapped to the SINV genome (strain TE12) using Geneious Mapper (https://geneious.com/features/prime) with a mapping quality of 30, a 10% gap, and a 20% mismatch rate. The standard counts-per-million (CPM) method (CPM = gene read count/total mapped reads × 1,000,000) was used to normalize for sequencing depth when comparing small RNA counts between samples. Logoplots showing nucleotide frequencies within vpiRNA reads were generated from 24- to 31-nt vpiRNA reads and visualized using WebLogo 3 (62). Small RNA-seq reads are available on the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) database (BioProject ID PRJNA1450706).
Virus constructs
All viral stop-codon mutant plasmids were generated by site-directed mutagenesis (see data S2 for primer details). WT and sense-codon variant SINV encoding eGFP, mCherry, and nLuc reporters were generated in our previous study (see data S2 for information regarding viral constructs) (1). The SINV E1-hsmut variant was generated using site-directed mutagenesis (see data S2 for primer details). Mutagenic primers were designed with the Takara’s In-Fusion Cloning Primer Design tool. PCR reactions were performed with Phusion polymerase (NEB) using the following cycling conditions: 1) 98°C for 30 s, 2) 98°C for 30 s, 3) 50°C for 30 s, 4) 72°C for 7 min (repeat steps 2 to 4 18×), 5) 72°C for 10 min, 6) hold at 4°C. Reactions were then treated with DpnI for 6 hours and purified with the Monarch PCR and DNA Clean-up Kit (NEB) according to the manufacturer’s protocol. The purified reaction was transformed into DH5α cells, and DNA was isolated with the Monarch Plasmid Miniprep Kit (NEB) according to the manufacturer’s protocol. Luciferase-based reporter viruses were generated by digesting parental and mutant plasmids with SpeI (NEB) and cloning in luciferase (Nano) using HiFi Gibson assembly (NEB). The Gibson reactions were then transformed into DH5α cells, and DNA was isolated with the Monarch Plasmid Miniprep Kit (NEB) according to the manufacturer’s protocol.
Viral infection assays
Viral infection assays were performed as described in our previous study (1). Briefly, 2 μg of infectious clones of WT and variant SINV expressing eGFP (TE3’2 J-3 × F-eGFP) was linearized with XhoI (NEB) and subjected to IVT with SP6 RNA polymerase (NEB) according to the manufacturer’s protocol (see data S2 for information regarding virus constructs). Cells were seeded into 24-well plates to reach 70 to 80% confluence and transfected with IVT using Lipofectamine LTX (Thermo Fisher Scientific) according to the manufacturer’s protocol. Cells were collected 48 hours posttransfection and analyzed by flow cytometry to quantify virus (eGFP)-positive cells (BD Fortessa). Infection rates for all variants were normalized to WT SINV (550opal).
Viral competition assays
Genome copy numbers of WT and mutant virus stocks were quantified by qRT-PCR (see data S2 for primer details). Briefly, cDNA synthesis was performed on the viral supernatant using M-MuLV Reverse Transcriptase (NEB) with oligo(dT) (20mer + 5′-Phos) (IDT) according to the manufacturer’s protocol. qRT-PCR was performed using the SYBR Green Master Mix (Thermo Fisher Scientific) with gene-specific primers on the Applied Biosystems StepOnePlus Real-Time PCR System (Life Technologies) according to the manufacturer’s protocol. WT and mutant SINV virus stocks were then normalized to equal genome copy numbers. WT and Dcr2 KO U4.4 cells and C6/36 cells were seeded into 24-well plates and infected with TE3′2 J-mCherry WT virus alongside TE3′2 J-eGFP WT or mutant viruses at a 1:1 ratio (MOI = 0.1). Cells were collected 48 hours postinfection and analyzed by flow cytometry (BD Fortessa) to determine the percentage of cells infected with WT (red) and variant (green) viruses. The viral competitive index was calculated as the ratio of variant (eGFP)-to-WT (mCherry)–infected cells within the population.
Generation of trans-heterozygous Dcr2 mutant mosquitoes
Dcr2 eGFP null line
We previously developed a transgenic line containing eGFP, as originally described in Basu et al. (22). Initially, we created an out-of-frame deletion using TALEN technology. Loss of function was confirmed by crossing into our “sensor” line and observing disease phenotypes following challenge with alphaviruses and flaviviruses (23, 63). Using the same TALEN target site, we knocked in a construct containing eGFP under the Poly-Ub promoter, as described in Basu et al. (22).
Dcr2 dsRED null line
For insertion of the dsRED-containing construct, we used sgRNA-directed Cas9 nuclease. The sgRNA was designed to target a site adjacent to the original TALEN site. We developed two distinct donor constructs with different homology arm sequences. Before creating these constructs, we sequenced the target site, revealing polymorphisms in the intronic regions of the homology arms. To account for this genetic variation, we generated donor constructs based on the two most prevalent homology arm sequences identified across individual mosquito specimens. Both donor constructs were coinjected during the transformation procedure. We confirmed one insertion site junction, but the second remains unverified. However, confirming genomic insertions in A. aegypti presents substantial technical challenges due to the genome’s architecture and heterogeneity, particularly the presence of numerous large introns containing many repetitive sequences and the previously mentioned polymorphisms.
Dcr2 homozygous knockouts
We generated trans-heterozygous Dcr2−/− mosquitoes by crossing two distinct Dcr2 mutant lines, one expressing eGFP (whole-body) and the other expressing dsRED (whole-body) (Fig. 2A). The progeny from these crosses were screened at the larval stage for fluorescent marker expression.
In vivo mosquito infections
Adult A. aegypti mosquitoes were infected by injecting 0.5 μl of SINV [106 median tissue culture infectious dose (TCID50)/ml] diluted in Dulbecco’s modified Eagle’s medium directly into the thorax. WT siblings, identified as negative for eGFP and dsRED fluorescence, served as controls. After inoculation, Dcr2-null (Dcr2−/−) mutants and WT siblings were maintained at 28°C and 80% relative humidity under a 14:10-hour light:dark cycle. Mosquitoes were collected at 0 and 72 hours postinfection in pools of five, flash-frozen in liquid nitrogen, and stored at −80°C until further analysis. qRT-PCR was performed to determine viral RNA levels in total RNA extracted from pools of five mosquitoes per replicate. A separate set of individual mosquitoes (n = 15 per condition) was collected and flash-frozen for quantification of infectious virus titer via TCID50 assays on Vero cells. Mosquitoes were homogenized in 60 μl of sterile 1× phosphate-buffered saline (PBS) containing protease inhibitor, and the homogenate was clarified by centrifugation through a 0.45-μm ultra-free polyvinylidene difluoride filter. Survival curves for WT SINV (550opal) were generated over 22 days for ≥28 female mosquitoes infected with 106 TCID50/ml WT SINV, comparing Dcr2+/+ and Dcr2−/− mosquitoes.
Total RNA extractions and real-time qRT-PCR analysis
To quantify minus- and plus-strand RNA copies, cells were seeded into a 24-well plate and infected with WT or variant strains at greater than 90% confluence. At 4 and 18 hours postinfection, cells were harvested with TRIzol reagent (Thermo Fisher Scientific), and RNA was extracted with the Direct-zol RNA Miniprep kit (Zymo) according to the manufacturer’s protocol. Following RNA extraction, cDNA was synthesized with M-MuLV Reverse Transcriptase (NEB) using strand-specific primers or oligoDT (20mer + 5′Phos) (IDT) according to the manufacturer’s protocol. In all cases, qRT-PCR was performed with SYBR Green master mix (Thermo Fisher Scientific) and plus-strand–specific primers on the Applied Biosystems StepOnePlus qRT-PCR machine (Life Technologies) (see data S2 for primer details).
Bulk RNA-seq
To quantify global transcriptomic changes, human A549 cells were infected with WT (550opal) and variant (550C) SINV at an MOI of 5. Mock- and virus-infected cells were collected 16 hours postinfection in Zymo DNA/RNA buffer and sent to Plasmidsaurus for bulk RNA-seq. Analysis was carried out by Plasmidsaurus using the following method: Quality of the fastq files was assessed using FastQC v0.12.1. Reads were then quality-filtered using fastp v0.24.0 with poly-X tail trimming, 3′ quality–based tail trimming, a minimum Phred quality score of 15, and a minimum length of 50 bp. Quality-filtered reads were aligned to the reference genome using STAR v2.7.11 with noncanonical splice junction removal and output of unmapped reads, followed by coordinate sorting with Samtools v1.22.1. PCR and optical duplicates were removed using unique molecular identifier (UMI)-based deduplication with UMIcollapse v1.1.0. Alignment quality metrics, strand specificity, and read distribution across genomic features were assessed using RSeQC v5.0.4 and Qualimap v2.3, and results were aggregated into a comprehensive quality control report using MultiQC v1.32. Gene-level expression quantification was performed using featureCounts (subread package v2.1.1) with strand-specific counting, multimapping read fractional assignment, exons, and three prime untranslated regions as the feature identifiers, and grouping by gene_id. Final gene counts were annotated with gene biotype, and other metadata were extracted from the reference GTF file. Differential expression was performed with edgeR v4.0.16 using the standard practice, including filtering for low-expressed genes with edgeR::filterByExpr using default values. RNA-seq reads are available on the NCBI SRA database (BioProject ID PRJNA1450807).
Viral replication assays
SINV nsP3-Nluc reporter viruses were generated by digesting 2 μg of plasmid DNA with XhoI and performing IVT with SP6 RNA polymerase (NEB) according to the manufacturer’s protocol. Cells were seeded into black-walled, clear-bottom 96-well plates at 70 to 80% confluency and transfected with 100 ng of capped viral RNA using Lipofectamine LTX (Thermo Fisher Scientific) according to the manufacturer’s protocol. At 48 hours posttransfection, translation was quantified using the NanoGlo luciferase assay system (Promega) according to the manufacturer’s protocol. Luminescence was measured using a Cytation3 Imaging Reader (BioTek).
IFN reporter activity
To quantify secreted IFN levels in infected WT, MDA5 KO, and MAVS KO A549 cells, cell supernatants from WT SINV (550opal) and 550C-infected cells were collected 16 hours postinfection and transferred to 5XISGF3-GLuc Huh7 reporter cells that stimulate production of Gaussia luciferase downstream of a 5XISRE reporter that is induced by ISGF3 (41). Reporter cells were incubated at 37°C and 5% CO2 for 48 hours to allow GLuc secretion into the media. Secreted GLuc was quantified using the Pierce Gaussia Luciferase Assay kit (Thermo Fisher Scientific) on a Cytation3 plate reader (BioTek) according to the manufacturer’s protocol. The 5XISGF3-GLuc Huh7 reporter cells were a gift from R. Savan (University of Washington). The RIG-I KO, MDA5 KO, and MAVS KO A549 cells were a gift from D. Stetson (University of Washington).
Western blot analyses
Cells were seeded into six-well plates and infected at an MOI of 5. After a 1-hour incubation at 4°C, cells were washed with cold 1× PBS, and lysates were harvested in radioimmunoprecipitation assay buffer (Pierce) supplemented with 1× protease inhibitor (cOmplete). Purified protein was denatured in 2× Laemmli buffer (Bio-Rad) with 5% β-mercaptoethanol (Sigma-Aldrich). Immunoblots were run on Mini-TGX precast gels and transferred to a Trans-Blot 0.2-μm nitrocellulose membrane using the Trans-Blot Turbo Transfer System (Bio-Rad). Blots were incubated overnight at 4°C in 5% bovine serum albumin (BSA) with the primary antibody at a 1:3000 dilution and then washed with 1× tris-buffered saline containing 0.1% Tween 20. Blots were probed with a secondary α-rabbit horseradish peroxidase conjugate (R&D Systems) and visualized using a Bio-Rad ChemiDoc Imaging System. Immunoblot probing for nonstructural protein expression and polyprotein processing were performed with independent biological replicates for each virus under different host conditions. Densitometry was carried out using FIJI/ImageJ (64).
Immunofluorescence confocal microscopy
Glass-bottom #1.5 coverslip 12-well plates (NC0190134; Thermo Fisher Scientific) were treated with 200 μl of sterile 0.01% poly-l-lysine (P4832; Sigma-Aldrich) per well for 1 hour at room temperature, rinsed once with DPBS++ (14-040-216; Thermo Fisher Scientific), and allowed to dry for 1 hour. U4.4 cells were seeded onto poly-l-lysine–coated wells and grown to ~20% confluency. Cells were then infected with WT or 550C SINV eGFP at a high MOI and incubated for 48 hours. Cells were rinsed twice with DPBS++ and fixed with 200 μl of 4% (v/v) paraformaldehyde (28906; Thermo Fisher Scientific) in DPBS++ for 10 min, followed by two washes. Permeabilization was performed with 400 μl of 0.05% Triton X-100 (BP151; Thermo Fisher Scientific) in DPBS++ for 5 min, followed by two washes. Cells were then blocked with 400 μl of 10% (w/v) BSA (BP9703100; Thermo Fisher Scientific) in DPBS++ for 1 hour.
Steps were performed in the dark to minimize photobleaching. Primary antibody staining was performed with 500 μl of mouse monoclonal anti-dsRNA J2 (1:1000) (76651L; Cell Signaling) in 5% BSA, incubated overnight at 4°C with gentle agitation. Cells were washed three times with DPBS++ and blocked again with 400 μl of 10% BSA in DPBS++ for 1 hour. Secondary antibody staining was performed with 500 μl of Alexa Fluor 633–conjugated goat anti-mouse antibody (1:1000) (A-21050; Invitrogen) in 5% BSA, and the sample was incubated overnight at 4°C without agitation. After a single wash with DPBS++, the nuclei were counterstained with Hoechst 33258 (1:1000) (H1398; Invitrogen) in 5% BSA for 15 min and then washed three times. Coverslips were mounted with 150 μl of SlowFade Diamond Antifade Mountant (S36972; Thermo Fisher Scientific). All steps were performed at room temperature unless otherwise noted. Each wash was performed with DPBS++ for 5 min. Imaging was performed on a Leica STELLARIS confocal microscope (DMi8 stand) with a 63× oil-immersion objective and Leica Application Suite X (LAS X) software. All comparative microscopy images were acquired on the same day with identical settings.
Microscopy imaging analysis
Images were analyzed using FIJI/ImageJ 1.54f with Java 1.8.0_322 (64-bit) and the ImageJ 3D Suite MCIB V3.96 (64–66). Spherule boundaries were determined by MaxEntropy thresholding of the anti-dsRNA Alexa Fluor 633 signal and used to create 3D regions of interest (ROIs). The accessibility of spherules to cytoplasmic eGFP was quantified as the mean eGFP signal intensity within entire spherules using the 3D Manager Quantif3D function in the ImageJ 3D Suite plugin. Spherule boundaries (fig. S12D) were determined by MaxEntropy thresholding of the anti-dsRNA Alexa Fluor 633 signal and used to create 3D ROIs. Reported mean eGFP signal intensities are per-spherule. Cellular dsRNA levels were quantified as the mean anti-dsRNA Alexa Fluor 633 signal using the 3D Manager Quantif3D function in the ImageJ 3D Suite plugin. Infected cells were identified by the presence of cytoplasmic eGFP and dsRNA. Cellular boundaries were determined by Otsu thresholding of the cytoplasmic eGFP signal, and areas excluding eGFP were filled using the binary “Fill in Holes” function, creating 3D ROIs as defined by the 3D Object Counter with a minimum threshold of 1500 cubic voxels. If needed, neighboring cells were separated across the entire stack before quantification using the 3D Watershed function in the ImageJ 3D Suite plugin. Nuclei were used as seeds. Reported mean J2 signal intensities are per cell.
Phylogenetics and RNA structure analysis
A multiple sequence alignment of nsP4 coding sequences from 49 extant alphavirus species was generated with Clustal Omega. The alignment was manually curated in Geneious, and a maximum-likelihood phylogenetic tree was inferred in PHYML using the HKY85 substitution model with 100 bootstrap replicates for statistical support. The tree was visualized with FigTree (https://tree.bio.ed.ac.uk/software/figtree/). RNA secondary structure conservation was assessed using RNAalifold on a multiple-sequence alignment of the 45-nt E1-hs region from 2086 alphavirus sequences collected from BV-BRC (v3.51.7) (67). SHAPE-constrained RNA secondary structure was generated with Vienna RNAfold and RNAcanvas using SHAPE-MaP data previously reported by Kutchko et al. and Madden et al. (31, 32, 68).
Statistics
Statistical analyses were performed using GraphPad Prism (v10.2, GraphPad Software Inc., San Diego, CA, https://graphpad.com). Data were first assessed for normality (Gaussian distribution) using the Kolmogorov-Smirnov test. For data meeting normality (α = 0.05) and homogeneity of variance criteria, means were compared using a two-way ANOVA (for multiple groups with two variables), unless otherwise stated, with post hoc tests for multiple comparisons. Some data were log-transformed before statistical testing to satisfy assumptions of normality. In these cases, tests were performed on the transformed values.
Acknowledgments
We thank the members of the Malik and Emerman laboratories for valuable discussions and acknowledge M. Levy, P. Dietzen, and R. F. Alves for feedback on the manuscript. We thank R. W. Hardy and S. (Tuli) Mukhopadhyay (Indiana University Bloomington) for sharing critical reagents, including the parental SINV infectious clone plasmids and E1/E2 polyclonal serum. We are grateful to R. Savan (University of Washington) for sharing 5XISGF3-GLuc Huh7 reporter cells and to D. Stetson (University of Washington) for sharing RIG-I KO, MDA5 KO, and MAVS KO A549 cells. We thank the Hutch Shared Resources, especially the Genomics and Flow Cytometry Core Facilities, for technical support.
Funding:
Shared resources grant support was by the Helen Hay Whitney Fellowship (to T.B.), the National Institutes of Health grant U54 AI170792 (PI: N. Krogan) (to M.E. and H.S.M.), the National Institutes of Health grant AI141532 (to K.M.M.), and the Howard Hughes Medical Institute Investigator Award (to H.S.M.). Funding agencies had no role in the execution of the project or in the decision to publish.
Author contributions:
Conceptualization: T.B., T.S.F., E.M.A., and H.S.M. Methodology: T.B., T.S.F., E.M.A., F.W., K.M.M., and H.S.M. Investigation: T.B., T.S.F., E.M.A., F.W., and H.S.M. Formal analysis: T.B., T.S.F., and E.M.A. Validation: T.B., T.S.F., E.M.A., and H.S.M. Visualization: T.B., T.S.F., and H.S.M. Resources: T.B., T.S.F., L.C., and K.M.M. Software: T.B. Data curation: T.B., T.S.F., and K.M.M. Funding acquisition: T.B., K.M.M., and H.S.M. Project administration: T.B., K.M.M., and H.S.M. Supervision: T.B., M.E., K.M.M., and H.S.M. Writing—original draft: T.B., T.S.F., and H.S.M. Writing—review and editing: T.B., T.S.F., E.M.A., L.C., M.E., K.M.M., and H.S.M.
Competing interests:
The authors declare that they have no competing interests.
Data, code, and materials availability:
All data and code needed to evaluate and reproduce the results in the paper are present in the paper and/or the Supplementary Materials. Requests for reagents generated in this study should be directed to the corresponding author, T.B. (tbhattac@fredhutch.org). Sequencing data are available on the NCBI SRA database under BioProjects PRJNA1450706 (https://dataview.ncbi.nlm.nih.gov/object/PRJNA1450706?reviewer=si4uff71f4sc636g99qrbj0pdu) and PRJNA1450807 (https://dataview.ncbi.nlm.nih.gov/object/PRJNA1450807?reviewer=72ifvm2c8jcvsfakr7gp1p624j).
Supplementary Materials
The PDF file includes:
Figs. S1 to S13
Legends for data S1 and S2
Other Supplementary Material for this manuscript includes the following:
Data S1 and S2
REFERENCES
- 1.Bhattacharya T., Alleman E. M., Freeman T. S., Noyola A. C., Emerman M., Malik H. S., A conserved opal termination codon optimizes a temperature-dependent trade-off between protein production and processing in alphaviruses. Sci. Adv. 11, eads7933 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rupp J. C., Sokoloski K. J., Gebhart N. N., Hardy R. W., Alphavirus RNA synthesis and non-structural protein functions. J. Gen. Virol. 96, 2483–2500 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Li G. P., Rice C. M., Mutagenesis of the in-frame opal termination codon preceding nsP4 of Sindbis virus: Studies of translational readthrough and its effect on virus replication. J. Virol. 63, 1326–1337 (1989). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Myles K. M., Kelly C. L. H., Ledermann J. P., Powers A. M., Effects of an opal termination codon preceding the nsP4 gene sequence in the O’Nyong-Nyong virus genome on Anopheles gambiae infectivity. J. Virol. 80, 4992–4997 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jones J. E., Long K. M., Whitmore A. C., Sanders W., Thurlow L. R., Brown J. A., Morrison C. R., Vincent H., Peck K. M., Browning C., Moorman N., Lim J. K., Heise M. T., Disruption of the opal stop codon attenuates chikungunya virus-induced arthritis and pathology. mBio 8, e01456-17 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mounce B. C., Cesaro T., Vlajnić L., Vidiņa A., Vallet T., Weger-Lucarelli J., Passoni G., Stapleford K. A., Levraud J.-P., Vignuzzi M., Chikungunya virus overcomes polyamine depletion by mutation of nsP1 and the opal stop codon to confer enhanced replication and fitness. J. Virol. 91, e00344-17 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.R. Li, K. Sun, A. Tuplin, M. Harris, A structural and functional analysis of opal stop codon translational readthrough during Chikungunya virus replication. bioRxiv 550286 [Preprint] (2023). 10.1101/2023.07.24.550286. [DOI] [PMC free article] [PubMed]
- 8.Hwang Kim K., Rümenapf T., Strauss E. G., Strauss J. H., Regulation of Semliki Forest virus RNA replication: A model for the control of alphavirus pathogenesis in invertebrate hosts. Virology 323, 153–163 (2004). [DOI] [PubMed] [Google Scholar]
- 9.Weaver S. C., Brault A. C., Kang W., Holland J. J., Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J. Virol. 73, 4316–4326 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Nasar F., Palacios G., Gorchakov R. V., Guzman H., Da Rosa A. P. T., Savji N., Popov V. L., Sherman M. B., Lipkin W. I., Tesh R. B., Weaver S. C., Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc. Natl. Acad. Sci. U.S.A. 109, 14622–14627 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hermanns K., Marklewitz M., Zirkel F., Overheul G. J., Page R. A., Loaiza J. R., Drosten C., van Rij R. P., Junglen S., Agua Salud alphavirus defines a novel lineage of insect-specific alphaviruses discovered in the New World. J. Gen. Virol. 101, 96–104 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hermanns K., Zirkel F., Kopp A., Marklewitz M., Rwego I. B., Estrada A., Gillespie T. R., Drosten C., Junglen S., Discovery of a novel alphavirus related to Eilat virus. J. Gen. Virol. 98, 43–49 (2017). [DOI] [PubMed] [Google Scholar]
- 13.Myles K. M., Wiley M. R., Morazzani E. M., Adelman Z. N., Alphavirus-derived small RNAs modulate pathogenesis in disease vector mosquitoes. Proc. Natl. Acad. Sci. 105, 19938–19943 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Altinli M., Leggewie M., Badusche M., Gyanwali R., Scherer C., Schulze J., Sreenu V. B., Fegebank M., Zibrat B., Fuss J., Junglen S., Schnettler E., Antiviral RNAi response against the insect-specific Agua Salud Alphavirus. mSphere 7, e0100321 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Siu R. W. C., Fragkoudis R., Simmonds P., Donald C. L., Chase-Topping M. E., Barry G., Attarzadeh-Yazdi G., Rodriguez-Andres J., Nash A. A., Merits A., Fazakerley J. K., Kohl A., Antiviral RNA interference responses induced by Semliki Forest virus infection of mosquito cells: Characterization, origin, and frequency-dependent functions of virus-derived small interfering RNAs. J. Virol. 85, 2907–2917 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sabin L. R., Zheng Q., Thekkat P., Yang J., Hannon G. J., Gregory B. D., Tudor M., Cherry S., Dicer-2 processes diverse viral RNA species. PLOS ONE 8, e55458 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gestuveo R. J., Parry R., Dickson L. B., Lequime S., Sreenu V. B., Arnold M. J., Khromykh A. A., Schnettler E., Lambrechts L., Varjak M., Kohl A., Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs. PLOS Pathog. 18, e1010202 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Brackney D. E., Scott J. C., Sagawa F., Woodward J. E., Miller N. A., Schilkey F. D., Mudge J., Wilusz J., Olson K. E., Blair C. D., Ebel G. D., C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. PLOS Negl. Trop. Dis. 4, e856 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Simpson D. A., Davis N. L., Lin S.-C., Russell D., Johnston R. E., Complete nucleotide sequence and full-length cDNA clone of S.A.AR86, a South African alphavirus related to Sindbis. Virology 222, 464–469 (1996). [DOI] [PubMed] [Google Scholar]
- 20.Weinbren M. P., Kokernot R. H., Smithburn K. C., Strains of Sindbis-like virus isolated from culicine mosquitoes in the Union of South Africa. I. Isolation and properties. S. Afr. Med. J. 30, 631–636 (1956). [PubMed] [Google Scholar]
- 21.Russell D. L., Dalrymple J. M., Johnston R. E., Sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice. J. Virol. 63, 1619–1629 (1989). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Basu S., Aryan A., Overcash J. M., Samuel G. H., Anderson M. A. E., Dahlem T. J., Myles K. M., Adelman Z. N., Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti. Proc. Natl. Acad. Sci. U.S.A. 112, 4038–4043 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Samuel G. H., Pohlenz T., Dong Y., Coskun N., Adelman Z. N., Dimopoulos G., Myles K. M., RNA interference is essential to modulating the pathogenesis of mosquito-borne viruses in the yellow fever mosquito Aedes aegypti. Proc. Natl. Acad. Sci. U.S.A. 120, e2213701120 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Miesen P., Girardi E., van Rij R. P., Distinct sets of PIWI proteins produce arbovirus and transposon-derived piRNAs in Aedes aegypti mosquito cells. Nucleic Acids Res. 43, 6545–6556 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Miesen P., Joosten J., van Rij R. P., PIWIs Go Viral: Arbovirus-derived piRNAs in vector mosquitoes. PLOS Pathog. 12, e1006017 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Morazzani E. M., Wiley M. R., Murreddu M. G., Adelman Z. N., Myles K. M., Production of virus-derived ping-pong-dependent piRNA-like small RNAs in the mosquito soma. PLOS Pathog. 8, e1002470 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Varjak M., Maringer K., Watson M., Sreenu V. B., Fredericks A. C., Pondeville E., Donald C. L., Sterk J., Kean J., Vazeille M., Failloux A.-B., Kohl A., Schnettler E., Aedes aegypti Piwi4 is a noncanonical PIWI protein involved in antiviral responses. mSphere 2, e00144-17 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vodovar N., Bronkhorst A. W., van Cleef K. W. R., Miesen P., Blanc H., van Rij R. P., Saleh M.-C., Arbovirus-derived piRNAs exhibit a ping-pong signature in mosquito cells. PLOS ONE 7, e30861 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tan Y. B., Chmielewski D., Law M. C. Y., Zhang K., He Y., Chen M., Jin J., Luo D., Molecular architecture of the Chikungunya virus replication complex. Sci. Adv. 8, eadd2536 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Schnettler E., Donald C. L., Human S., Watson M., Siu R. W. C., McFarlane M., Fazakerley J. K., Kohl A., Fragkoudis R., Knockdown of piRNA pathway proteins results in enhanced Semliki Forest virus production in mosquito cells. J. Gen. Virol. 94, 1680–1689 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kutchko K. M., Madden E. A., Morrison C., Plante K. S., Sanders W., Vincent H. A., Cruz Cisneros M. C., Long K. M., Moorman N. J., Heise M. T., Laederach A., Structural divergence creates new functional features in alphavirus genomes. Nucleic Acids Res. 46, 3657–3670 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Madden E. A., Plante K. S., Morrison C. R., Kutchko K. M., Sanders W., Long K. M., Taft-Benz S., Cruz Cisneros M. C., White A. M., Sarkar S., Reynolds G., Vincent H. A., Laederach A., Moorman N. J., Heise M. T., Using SHAPE-MaP to model RNA secondary structure and identify 3′UTR variation in chikungunya virus. J. Virol. 94, e00701-20 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.C. Bou-Nader, K. M. Juma, A. Bothra, A. J. Brasington, R. Ghirlando, M. Suzuki, D. N. Garboczi, S. H. Leppla, J. Zhang, Specificity and mechanism of the double-stranded RNA-specific J2 monoclonal antibody. bioRxiv 649859 [Preprint] (2025). 10.1101/2025.05.09.649859. [DOI] [PMC free article] [PubMed]
- 34.Hellström K., Kallio K., Utt A., Quirin T., Jokitalo E., Merits A., Ahola T., Partially uncleaved alphavirus replicase forms spherule structures in the presence and absence of RNA template. J. Virol. 91, e00787-17 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Frolova E. I., Gorchakov R., Pereboeva L., Atasheva S., Frolov I., Functional Sindbis virus replicative complexes are formed at the plasma membrane. J. Virol. 84, 11679–11695 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ahola T., McInerney G., Merits A., Alphavirus RNA replication in vertebrate cells. Adv. Virus Res. 111, 111–156 (2021). [DOI] [PubMed] [Google Scholar]
- 37.Liu J., Swevers L., Kolliopoulou A., Smagghe G., Arboviruses and the challenge to establish systemic and persistent infections in competent mosquito vectors: The interaction with the RNAi mechanism. Front. Physiol. 10, 890 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sánchez-Vargas I., Scott J. C., Poole-Smith B. K., Franz A. W. E., Barbosa-Solomieu V., Wilusz J., Olson K. E., Blair C. D., Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito’s RNA interference pathway. PLOS Pathog. 5, e1000299 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Nikonov A., Mölder T., Sikut R., Kiiver K., Männik A., Toots U., Lulla A., Lulla V., Utt A., Merits A., Ustav M., RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLOS Pathog. 9, e1003610 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Akhrymuk I., Frolov I., Frolova E. I., Both RIG-I and MDA5 detect alphavirus replication in concentration-dependent mode. Virology 487, 230–241 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Smith J. R., Dowling J. W., McFadden M. I., Karp A., Schwerk J., Woodward J. J., Savan R., Forero A., MEF2A suppresses stress responses that trigger DDX41-dependent IFN production. Cell Rep. 42, 112805 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Chitrakar A., Rath S., Donovan J., Demarest K., Li Y., Sridhar R. R., Weiss S. R., Kotenko S. V., Wingreen N. S., Korennykh A., Real-time 2-5A kinetics suggest that interferons β and λ evade global arrest of translation by RNase L. Proc. Natl. Acad. Sci. U.S.A. 116, 2103–2111 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cruz C. C., Suthar M. S., Montgomery S. A., Shabman R., Simmons J., Johnston R. E., Morrison T. E., Heise M. T., Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein. Virology 399, 1–10 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Liu X., Mutso M., Utt A., Lepland A., Herrero L. J., Taylor A., Bettadapura J., Rudd P. A., Merits A., Mahalingam S., Decreased virulence of ross river virus harboring a mutation in the first cleavage site of nonstructural polyprotein is caused by a novel mechanism leading to increased production of interferon-inducing RNAs. mBio 9, e00044-18 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kril V., Hons M., Amadori C., Zimberger C., Couture L., Bouery Y., Burlaud-Gaillard J., Karpov A., Ptchelkine D., Thienel A. L., Kümmerer B. M., Desfosses A., Jones R., Roingeard P., Meertens L., Amara A., Reguera J., Alphavirus nsP3 organizes into tubular scaffolds essential for infection and the cytoplasmic granule architecture. Nat. Commun. 15, 8106 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Girard J., Le Bihan O., Lai-Kee-Him J., Girleanu M., Bernard E., Castellarin C., Chee M., Neyret A., Spehner D., Holy X., Favier A.-L., Briant L., Bron P., In situ fate of Chikungunya virus replication organelles. J. Virol. 98, e00368-24 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Liu Y., Wang J., Han Y., Xia X., Zeng R., Fan X., Zhang B., Wang K., Lei J., Cryo-EM reveals a double oligomeric ring scaffold of the CHIKV nsP3 peptide in complex with the NTF2L domain of host G3BP1. mBio 16, e0396724 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Laurent T., Kumar P., Liese S., Zare F., Jonasson M., Carlson A., Carlson L.-A., Architecture of the chikungunya virus replication organelle. eLife 11, e83042 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Shin G., Yost S. A., Miller M. T., Elrod E. J., Grakoui A., Marcotrigiano J., Structural and functional insights into alphavirus polyprotein processing and pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 109, 16534–16539 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Bartholomeeusen K., Utt A., Coppens S., Rausalu K., Vereecken K., Ariën K. K., Merits A., A chikungunya virus trans-replicase system reveals the importance of delayed nonstructural polyprotein processing for efficient replication complex formation in mosquito cells. J. Virol. 92, e00152-18 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Moon S. L., Dodd B. J. T., Brackney D. E., Wilusz C. J., Ebel G. D., Wilusz J., Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery. Virology 485, 322–329 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.van Cleef K. W. R., van Mierlo J. T., Miesen P., Overheul G. J., Fros J. J., Schuster S., Marklewitz M., Pijlman G. P., Junglen S., van Rij R. P., Mosquito and Drosophila entomobirnaviruses suppress dsRNA- and siRNA-induced RNAi. Nucleic Acids Res. 42, 8732–8744 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Aliyari R., Wu Q., Li H.-W., Wang X.-H., Li F., Green L. D., Han C. S., Li W.-X., Ding S.-W., Mechanism of induction and suppression of antiviral immunity directed by virus-derived small RNAs in Drosophila. Cell Host Microbe 4, 387–397 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Chao J. A., Lee J. H., Chapados B. R., Debler E. W., Schneemann A., Williamson J. R., Dual modes of RNA-silencing suppression by Flock House virus protein B2. Nat. Struct. Mol. Biol. 12, 952–957 (2005). [DOI] [PubMed] [Google Scholar]
- 55.Cirimotich C. M., Scott J. C., Phillips A. T., Geiss B. J., Olson K. E., Suppression of RNA interference increases alphavirus replication and virus-associated mortality in Aedes aegypti mosquitoes. BMC Microbiol. 9, 49 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Mathur K., Anand A., Dubey S. K., Sanan-Mishra N., Bhatnagar R. K., Sunil S., Analysis of chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity. Sci. Rep. 6, 38065 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Qian Q., Zhou H., Shu T., Mu J., Fang Y., Xu J., Li T., Kong J., Qiu Y., Zhou X., The capsid protein of Semliki Forest virus antagonizes RNA interference in mammalian cells. J. Virol. 94, e01233-19 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Gupta A. K., Wiley M. R., Myles K. M., Antagonism of RNA silencing in the yellow fever mosquito, Aedes aegypti, by the nsP2 protein of the prototype alphavirus. Proc. Natl. Acad. Sci. U.S.A. 123, e2521417123 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Omler A., Rutmane A., Mahalingam S., Merits A., The ability of alphavirus replicases to synthesize non-viral type I interferon-inducing RNAs correlates with viral RNA synthesis and has a diverse impact on virus replication and pathogenicity. J. Virol. 100, e0216225 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Heise M. T., Simpson D. A., Johnston R. E., A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86. J. Virol. 74, 4207–4213 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Brinkman E. K., Chen T., Amendola M., van Steensel B., Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Crooks G. E., Hon G., Chandonia J.-M., Brenner S. E., WebLogo: A sequence logo generator. Genome Res. 14, 1188–1190 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Adelman Z. N., Anderson M. A. E., Morazzani E. M., Myles K. M., A transgenic sensor strain for monitoring the RNAi pathway in the yellow fever mosquito, Aedes aegypti. Insect Biochem. Mol. Biol. 38, 705–713 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.-Y., White D. J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A., Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Ollion J., Cochennec J., Loll F., Escudé C., Boudier T., TANGO: A generic tool for high-throughput 3D image analysis for studying nuclear organization. Bioinformatics 29, 1840–1841 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Schroeder A. B., Dobson E. T. A., Rueden C. T., Tomancak P., Jug F., Eliceiri K. W., The ImageJ ecosystem: Open-source software for image visualization, processing, and analysis. Protein Sci. 30, 234–249 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Bernhart S. H., Hofacker I. L., Will S., Gruber A. R., Stadler P. F., RNAalifold: Improved consensus structure prediction for RNA alignments. BMC Bioinformatics 9, 474 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Johnson P. Z., Simon A. E., RNAcanvas: Interactive drawing and exploration of nucleic acid structures. Nucleic Acids Res. 51, W501–W508 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figs. S1 to S13
Legends for data S1 and S2
Data S1 and S2
Data Availability Statement
All data and code needed to evaluate and reproduce the results in the paper are present in the paper and/or the Supplementary Materials. Requests for reagents generated in this study should be directed to the corresponding author, T.B. (tbhattac@fredhutch.org). Sequencing data are available on the NCBI SRA database under BioProjects PRJNA1450706 (https://dataview.ncbi.nlm.nih.gov/object/PRJNA1450706?reviewer=si4uff71f4sc636g99qrbj0pdu) and PRJNA1450807 (https://dataview.ncbi.nlm.nih.gov/object/PRJNA1450807?reviewer=72ifvm2c8jcvsfakr7gp1p624j).







